Daye Peak Research to Develop "Double Carbon" Action Plan
Release time:
2021-12-01
News from our newspaper # February 17 , daye peak cement company focused on the in-depth discussion of the future "carbon peak, carbon neutrality" work at the 2021 management review meeting, and studied and formulated an action plan. In the
meeting, the heads of various departments participating in the meeting conducted a collective study on the national "double carbon" work plan, the energy double control policy of Hubei Province, and the GB16780-2021 standard. Each department proposed corresponding improvement measures based on the changes in the internal and external environment of the enterprise and the "double carbon" policy trend, combined with the current work situation of the department. According to the current actual operation status of the production line, the manufacturing department makes a benchmarking analysis of key energy consumption projects, and points out the gap with the advanced enterprises in the same industry and the "double carbon" requirements. The Ministry of Environmental Security put forward its views on the ultra-clean emission plan to be issued in Hubei Province. The Quality Control Department puts forward suggestions on the optimization of quality process control and the substitution of mixed materials. The marketing department, the general department and other departments also put forward management improvement opinions on the actual work of the department.
After discussion, Daye Peak has initially formed technical renovation projects such as adding a new primary preheater, carrying out oxygen-enriched combustion renovation, treating alternative fuels, adding photovoltaic power generation facilities, adding a cyclone to the chimney at the end of the kiln or increasing the desulfurization tower, and reforming the large cloth bag of the coal mill. It has also put forward three-year action goals of reducing coal consumption, total energy consumption and carbon emissions, strive to complete the requirements of the Ministry of Industry and Information Technology's "14th Five-Year Plan" national cleaner production implementation plan ahead of schedule. At the meeting, relevant plans and improvement methods will be discussed, implementation or demonstration opinions will be put forward, and the specific responsible persons for each project will be identified. Zhang Fengliang, deputy general manager of
Group Company and general manager of Daye Peak, stressed in the discussion that the complex and changeable external economic environment, the background of "carbon peak and carbon neutrality", the increasingly tightening energy double control policy of the state, provinces and cities, and the introduction of the ultra-clean emission policy of environmental protection departments have all pushed cement, a traditional high energy-consuming industry, into an unprecedented situation of challenges and opportunities. As the backbone enterprise of the peak, Daye peak must recognize the environment faced by the enterprise, grasp the bull nose of "double carbon" and ultra-clean emission with the sense of responsibility and innovation, open up ideas, change concepts, take energy saving, consumption reduction and clean production as the main line, plan the layout for the future development of the enterprise, make Daye peak in the forefront of the industry in terms of low consumption, low carbon and ultra-clean emission of pollutants, and master the initiative in order to resist the cold winter, in the rapidly changing environment to win the opportunity, seize the opportunity, and continue to grow and develop.
(Wang Yiyan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page